Bevacizumab and fatigue 
Bevacizumab and fatigue Patient Reports February 10, 2012
Bevacizumab Side Effects Report #5230838-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 05, 2007. Male patient, 76 years of age, weighting 172.0 lb, was diagnosed with tonsil cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, fatigue, oral intake reduced, weight decreased. Bevacizumab dosage: 10 MG/KG Q 2 WEEKS IV. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE, RADIATION. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5807606-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 02, 2008. Female patient, weighting 160.3 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, pyrexia, staphylococcal bacteraemia. Bevacizumab dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, METHYLPHENIDATE, HYDROCODONE, TYLENOL PM, ESOMEPRAZOLE MAGNESIUM, ESCITALOPRAM, ALPRAZOLAM, POTASSIUM PHOSPHATE MONOBASIC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5914027-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 29, 2008. Female patient, weighting 160.3 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, METHYLPHENIDATE, HYDROCODONE BITARTRATE, TYLENOL, ESOMEPRAZOLE MAGNESIUM, ESCITALOPRAM, ALPRAZOLAM, POTASSIUM PHOSPHATE MONOBASIC. Patient recovered.
Bevacizumab Side Effects Report #5924253-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 08, 2008. Female patient, weighting 160.3 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, METHYLPHENIDATE, HYDROCODONE BITARTRATE, TYLENOL, ESOMEPRAZOLE MAGNESIUM, ESCITALOPRAM, ALPRAZOLAM, POTASSIUM PHOSPHATE MONOBASIC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5967782-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 18, 2008. Female patient, weighting 160.3 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, METHYLPHENIDATE, HYDROCODONE BITARTRATE, TYLENOL, ESOMEPRAZOLE MAGNESIUM, ESCITALOPRAM, ALPRAZOLAM, POTASSIUM PHOSPHATE MONOBASIC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6038904-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 14, 2009. Male patient, weighting 174.2 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: clostridium bacteraemia, fatigue, haemoglobin decreased, hypercalcaemia. Bevacizumab dosage: 15 MG/KG Q 21 DAYS IV. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5224744-7
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 29, 2007. Male patient, 72 years of age, weighting 186.0 lb, was diagnosed with prostate cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, chills, dehydration, fatigue, mucosal inflammation, myalgia, nausea , pyrexia, unevaluable event. Bevacizumab dosage: 455 MG X1 IV. During the same period patient was treated with DOCETAXEL, CHEMO, LISINOPRIL, POTASSIUM ACETATE, FERROS GLUCONATE, FUROSEMIDE, GLYBURIDE, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5008454-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 22, 2006. Male patient, weighting 250.0 lb, was diagnosed with pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, chills, dehydration, diarrhoea, fatigue, flatulence, hypoaesthesia, hypotension. Bevacizumab dosage: 570 MG QS Q2 WKS. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, PROTONIX, SANDOSTATIN LAR. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5469617-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 25, 2007. Female patient, weighting 99.21 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia, fatigue, gastrointestinal haemorrhage, syncope. Bevacizumab dosage: 480MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient recovered.
Bevacizumab Side Effects Report #5747665-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 08, 2008. Female patient, weighting 121.3 lb, was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood magnesium decreased, dizziness
, fatigue, haemoglobin decreased, hypokalaemia, neuropathy peripheral, thrombocytopenia, tinnitus . Bevacizumab dosage: 412.5 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5751407-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 14, 2008. Female patient, weighting 121.3 lb, was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood magnesium decreased, fatigue, haemoglobin decreased, hypokalaemia, peripheral sensory neuropathy, thrombocytopenia. Bevacizumab dosage: 412.5 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5760015-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 21, 2008. Female patient, weighting 121.3 lb, was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, peripheral sensory neuropathy. Bevacizumab dosage: 412.5 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5508187-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 29, 2007. Male patient, 73 years of age, weighting 78.93 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, fatigue. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, IMODIUM, REGLAN, NORVASC, LIPITOR, MEGACE, NYSTATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5557421-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 10, 2007. Male patient, 73 years of age, weighting 78.93 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, condition aggravated, fatigue, melaena. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, IMODIUM, REGLAN, NORVASC, LIPITOR, MEGACE, NYSTATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5868961-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 02, 2008. Male patient, weighting 145.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, atrial flutter, dehydration, fatigue, sinus tachycardia, weight decreased. Bevacizumab dosage: 987 MG IV. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5416836-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 15, 2007. Male patient, 81 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, asthenia, dehydration, fatigue, hypernatraemia, hypokalaemia, oral intake reduced, weight decreased. Bevacizumab dosage: 1050 MG Q21 DAYS IV. During the same period patient was treated with PEMETREXED, ERLOTINIB, PROSCAR, INDAPAMIDE, LISINOPRIL, TERAZOSIN, LIPITOR, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5386668-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 06, 2007. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, infection
. Bevacizumab dosage: 1082 MG, Q3W. During the same period patient was treated with CETUXIMAB, CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient died on 03/20/2007.Bevacizumab Side Effects Report #5296107-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dizziness
, fatigue. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, REGLAN, PROCRIT. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5318211-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 02, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dizziness
, fatigue. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, REGLAN, PROCRIT. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5326628-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 01, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, fatigue, hypokalaemia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5377473-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 20, 2007. Male patient, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, febrile bone marrow aplasia, jaundice
, pyrexia. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, VINORELBINE, FENTANYL, FORLAX, ACTISKENAN, NEXIUM, LEXOMIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5419471-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 14, 2007. Male patient, weighting 142.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, hypernatraemia, hypokalaemia, weight decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, PEMETREXED, PROSCAR, INDAPAMIDE, LISINOPRIL, TERAZOSIN, LIPITOR, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5444002-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 29, 2007. Male patient, weighting 142.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, hypernatraemia, hypokalaemia, weight decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, PEMETREXED, PROSCAR, INDAPAMIDE, LISINOPRIL, TERAZOSIN, LIPITOR, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5471951-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 14, 2007. Male patient, weighting 145.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, fatigue, pyrexia. Bevacizumab dosage: 960 MG, UNK. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5537437-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 23, 2007. Male patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: creatinine renal clearance decreased, fatigue. Bevacizumab dosage: 970 MG, Q3W. During the same period patient was treated with ROCEPHIN. Patient was hospitalized and became disabled. Patient recovered.
Bevacizumab Side Effects Report #5547267-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 28, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, cardiomyopathy
, fatigue. Bevacizumab dosage: 609 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5631396-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 04, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, cardiomyopathy
, fatigue. Bevacizumab dosage: 609 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5717059-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 09, 2008. Female patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with BISOPROLOL FUMARATE, COZAAR, AMLODIPINE, SPIRON, FUROSEMIDE, SIMVASTATIN, NEXIUM, ACETYLCYSTEINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5725717-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 22, 2008. Female patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, epistaxis, fatigue, neutrophil count decreased, pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with BISOPROLOL FUMARATE, COZAAR, AMLODIPINE, SPIRON, FUROSEMIDE, SIMVASTATIN, NEXIUM, ACETYLCYSTEINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5745846-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 12, 2008. Female patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, neutrophil count decreased, pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with BISOPROLOL FUMARATE, COZAAR, AMLODIPINE, SPIRON, FUROSEMIDE, SIMVASTATIN, NEXIUM, ACETYLCYSTEINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5758676-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 21, 2008. Female patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: epistaxis, fatigue, neutrophil count decreased, pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with BISOPROLOL FUMARATE, COZAAR, AMLODIPINE, SPIRON, FUROSEMIDE, SIMVASTATIN, NEXIUM, ACETYLCYSTEINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5777923-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 03, 2008. Female patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, neutrophil count decreased, pyrexia, white blood cell count decreased. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with BISOPROLOL FUMARATE, COZAAR, AMLODIPINE, SPIRON, FUROSEMIDE, SIMVASTATIN, NEXIUM, ACETYLCYSTEINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6011351-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation
, fatigue, lymphocyte count decreased. Bevacizumab dosage: 15 MG/KG, Q14D. During the same period patient was treated with INTERFERON ALFA. Patient recovered.Bevacizumab Side Effects Report #5498601-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2007. Male patient, weighting 174.2 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, febrile neutropenia, muscle spasms, nausea
, small intestinal obstruction. Bevacizumab dosage: 10MG/MG2 IV BOLUS. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4897413-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 30, 2006. Female patient, weighting 114.6 lb, was diagnosed with metastasis, transitional cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, confusional state, dysarthria, fatigue, foaming at mouth, grand mal convulsion, headache
, hypertensive encephalopathy, loss of consciousness. Bevacizumab dosage: 15MG/KG -806MG, 834MG, 780MG ONCE EVERY 3 WEEKS IV DRIP. Patient recovered.Bevacizumab Side Effects Report #5021746-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2006. Male patient, 67 years of age, weighting 250.0 lb, was diagnosed with insulinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, chills, dehydration, diarrhoea, fatigue, vomiting. Bevacizumab dosage: 570 MG, Q2W, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, PROTONIX, SANDOSTATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6059941-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 23, 2009. Male patient, weighting 148.6 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial flutter, cardiomyopathy
, diarrhoea, fatigue. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with COMPAZINE, IMODIUM, OPIUM TINCTURE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5744649-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 12, 2008. Female patient, 64 years of age, was diagnosed with head and neck cancer
, hypertension and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: delirium, fatigue. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, RADIATION, LISINOPRIL, AMLODIPINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6081133-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 09, 2009. Male patient, weighting 256.0 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, fatigue, muscular weakness. Bevacizumab dosage: 5 MG/KG, D1. During the same period patient was treated with SORAFENIB. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4799983-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2005. Male patient, 69 years of age, weighting 194.3 lb, was diagnosed with gastrooesophageal cancer, metastasis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, fall
, fatigue, haemoglobin decreased. Bevacizumab dosage: 15MG/KG IV EVERY 21 DAY. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, FERROUS SULPHATE, MOTRIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5062789-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2006. Male patient, weighting 190.0 lb, was diagnosed with endocrine neoplasm, pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, anaemia, asthenia, fatigue, gastritis erosive, ileus, liver abscess, platelet count decreased, pyrexia. Bevacizumab dosage: 465 MG QS Q2WEEKS IV. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5485998-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 01, 2007. Male patient was diagnosed with diffuse large b-cell lymphoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, dysphagia, fatigue, muscular weakness, neuropathy, neutrophil count decreased, white blood cell count decreased. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5485999-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 01, 2007. Male patient was diagnosed with diffuse large b-cell lymphoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, confusional state, dysphagia, faecal incontinence, fatigue, lethargy, lymphoma
, malaise, muscular weakness. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4694820-6
Bevacizumab side effect was reported by a Health Professional from on June 06, 2005. Female patient, 81 years of age, weighting 129.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute prerenal failure, bacteria urine identified, blood calcium decreased, blood potassium decreased, diarrhoea, electrolyte imbalance, fatigue, gram stain positive, hyperglycaemia. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CLARITIN, VITAMIN, IRON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4822901-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 25, 2005. Female patient, 81 years of age, weighting 129.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute prerenal failure, blood calcium decreased, blood potassium decreased, diarrhoea, electrolyte imbalance, fatigue, gram stain positive, hyperglycaemia, hypotension. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CLARITIN, VITAMIN, IRON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5529488-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 14, 2007. Male patient, weighting 192.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, nausea
, pain , pyrexia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, FENTANYL TRANSDERMAL SYSTEM, DILAUDID, COMPAZINE, HYDROCODONE BITARTRATE, ROBAXIN, ZOFRAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5573799-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 13, 2007. Male patient, weighting 192.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, nausea
, pain , pyrexia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, FENTANYL TRANSDERMAL SYSTEM, DILAUDID, COMPAZINE, HYDROCODONE BITARTRATE, ROBAXIN, ZOFRAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5840767-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 28, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5957424-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 06, 2008. Female patient, weighting 132.3 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, creatinine renal clearance decreased, dehydration, diarrhoea, fatigue, nausea
, platelet count increased. Bevacizumab dosage: 450 MG, Q3W. During the same period patient was treated with CAPECITABINE, ASPIRIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5007480-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 15, 2006. Female patient, 81 years of age, weighting 129.0 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute prerenal failure, blood calcium decreased, blood potassium decreased, dehydration, diarrhoea, electrolyte imbalance, fatigue, hyperglycaemia, hypotension. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CLARITIN, VITAMIN, IRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5854857-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 08, 2008. Female patient, weighting 105.4 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, fatigue, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, AMLODIPINE, KYTRIL, DECADRON SRC, NOVAMIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 02/05/2008.
Bevacizumab Side Effects Report #6042389-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 05, 2009. Male patient, weighting 108.9 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, fatigue, pyrexia. Bevacizumab dosage: 240 MG, Q2W. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE, HANGE, COPTIS, GINSENG, GLYCYRRHIZA GLABRA, SCUTELLARIA BAICALENSIS, KYTRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4719259-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 19, 2005. Male patient, 64 years of age, weighting 205.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, mental status changes, pathogen resistance, urinary tract infection enterococcal. Bevacizumab dosage: 465.90 MG. INTRAVENOUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4724661-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 19, 2005. Male patient, 64 years of age, weighting 205.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: enterococcal infection, fatigue, mental status changes, urinary tract infection
. Bevacizumab dosage: 465.90 MG INTRAVENOUS. During the same period patient was treated with IRINOTECAN, LEUCOVORIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5718529-2
Bevacizumab side effect was reported by a Health Professional from UNITED KINGDOM on Apr 10, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: back pain
, cardio-respiratory arrest, cold sweat, fall , fatigue, myocardial ischaemia, neck pain, neuropathy peripheral, pulmonary embolism . Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, LEUCOVORIN CALCIUM. Patient died on 12/24/2005.Bevacizumab Side Effects Report #5958764-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2008. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, blood creatinine increased, dehydration, diarrhoea, fatigue, lethargy, malaise. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5582091-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 31, 2007. Female patient was diagnosed with cervix carcinoma, pain
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, decreased appetite, dysphonia, fatigue, renal failure, urine output decreased. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CISPLATIN, TOPOTECAN, VERAPAMIL, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, PERCOCET, MORPHINE, ZOFRAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4666706-4
Bevacizumab side effect was reported by a Health Professional from on May 02, 2005. Female patient, 63 years of age, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, constipation
, coordination abnormal, dehydration, dizziness , dyspepsia, fatigue, gastrooesophageal reflux disease, hyperglycaemia. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5117618-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 28, 2006. Female patient, 85 years of age, weighting 123.5 lb, was diagnosed with breast cancer female and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abasia, disease progression, failure to thrive, fatigue. Bevacizumab dosage: 15 MG/KG Q3WKS IV. Patient was hospitalized and became disabled. Patient recovered.
Bevacizumab Side Effects Report #5884894-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 15, 2008. Female patient, 46 years of age, weighting 154.1 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, cardiac failure, dyspnoea, fatigue, malaise, nausea , productive cough. Bevacizumab dosage: 15MG/KG IV Q 3 WEEKS. During the same period patient was treated with CAPECITABINE, ATIVAN, EFFEXOR. Patient was hospitalized. Patient died on 09/04/2008.Bevacizumab Side Effects Report #5551523-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 29, 2007. Female patient, weighting 167.6 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, headache , pyrexia, vomiting. Bevacizumab dosage: 760 MG, UNK. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5554526-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 30, 2007. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: epistaxis, fatigue, hypertension, palmar-plantar erythrodysaesthesia syndrome, wound complication. Bevacizumab dosage: 420 MG, QD. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5579600-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 19, 2007. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: epistaxis, fatigue, hypertension, palmar-plantar erythrodysaesthesia syndrome, wound complication. Bevacizumab dosage: 420 MG, QD. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5847145-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 01, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, diarrhoea, dizziness , dyspnoea, fatigue, headache , hypokalaemia, lethargy. Bevacizumab dosage: 10 MG/KG, DAYS 2+16. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6092826-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 12, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, stomatitis. Bevacizumab dosage: 1290 MG, Q3W. During the same period patient was treated with TRASTUZUMAB, CARBOPLATIN, DOCETAXEL, CIPROFLOXACIN, FLUCONAZOLE, RANITIDINE, COMPONENT, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6127177-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 05, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, stomatitis. Bevacizumab dosage: 1290 MG, Q3W. During the same period patient was treated with TRASTUZUMAB, CARBOPLATIN, DOCETAXEL, DEXAMETHASONE, ONDANSETRON, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6127221-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 05, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, stomatitis. Bevacizumab dosage: 1290 MG, Q3W. During the same period patient was treated with TRASTUZUMAB, CARBOPLATIN, DOCETAXEL, DEXAMETHASONE, ONDANSETRON, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4941195-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 10, 2006. Male patient, 43 years of age, weighting 160.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, blood bilirubin increased, cholangitis, decreased appetite, dehydration, diarrhoea, failure to thrive, fatigue, hepatic enzyme increased. Bevacizumab dosage: 10 MG/KG IV. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5320792-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 25, 2007. Female patient, weighting 154.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, erythema, fatigue. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with SORAFENIB, SERTRALINE, MIRANAX, HYDROCHLOROTHIAZIDE, RAMIPRIL, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5376077-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2007. Female patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aphasia
, bronchitis , candidiasis, confusional state, disease progression, fall , fatigue, loss of consciousness, muscular weakness. Bevacizumab dosage: unknown. During the same period patient was treated with ETOPOSIDE, DIOVAN, SINGULAIR, PERCO, NEXIUM, FLONASE, DEXAMETHASONE, DYNACIRC. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5135261-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2006. Female patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: agranulocytosis, asthenia, candidiasis, dehydration, diarrhoea, fatigue, oral intake reduced, white blood cell count decreased. Bevacizumab dosage: 274 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN, ALOXI, ARANESP, DEXAMETHASONE, IMODIUM, KYTRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5150484-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2006. Female patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: agranulocytosis, anorexia, asthenia, candidiasis, dehydration, diarrhoea, fatigue, lung infiltration, pleural effusion. Bevacizumab dosage: 274 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN, ALOXI, ARANESP, DEXAMETHASONE, IMODIUM, KYTRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5150512-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2006. Female patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: agranulocytosis, anorexia, asthenia, candidiasis, dehydration, diarrhoea, fatigue, lung infiltration, pleural effusion. Bevacizumab dosage: 274 MG. During the same period patient was treated with CAMPTOSAR, OXALIPLATIN, ALOXI, ARANESP, DEXAMETHASONE, IMODIUM, KYTRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5152067-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 13, 2006. Female patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: agranulocytosis, anorexia, asthenia, candidiasis, dehydration, diarrhoea, fatigue, lung infiltration, pleural effusion. Bevacizumab dosage: 274 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN, ALOXI, ARANESP, DEXAMETHASONE, IMODIUM, KYTRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5487626-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2007. Male patient, weighting 184.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: activities of daily living impaired, fatigue, impaired work ability. Bevacizumab dosage: 762 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN. Patient recovered.
Bevacizumab Side Effects Report #5631880-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 19, 2008. Male patient, weighting 184.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: activities of daily living impaired, cardiac failure congestive, dyspnoea exertional, fatigue, impaired work ability, left ventricular dysfunction, oedema peripheral, weight increased. Bevacizumab dosage: 762 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN. Patient recovered.
Bevacizumab Side Effects Report #5729788-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 31, 2008. Male patient, weighting 149.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, dysphagia, fatigue, weight decreased. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5809684-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2008. Male patient, weighting 149.9 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, dyspnoea exertional, fatigue, oxygen saturation decreased, therapeutic agent toxicity. Bevacizumab dosage: 675 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN, ACCUPRIL, NORVASC, QUINAPRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5818670-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2008. Male patient, weighting 149.9 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, dyspnoea exertional, fatigue. Bevacizumab dosage: 675 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN, ACCUPRIL, NORVASC, QUINAPRIL. Patient recovered.